Samantha Prout Net Worth & Insider Trades

Samantha Prout - Principal Accounting Officer, Amicus Therapeutics, Inc

As of September 8, 2021

What is Samantha Prout's Net Worth?

The current estimated net worth of Amicus Therapeutics, Inc's Principal Accounting Officer, Samantha Prout, is estimated to be about $540.93K . Samantha Prout owns about 83,170 units of Amicus Therapeutics, Inc common stock. In the last 2 years at Amicus Therapeutics, Inc, Samantha Prout has sold an estimated value of $387.49K worth.

What is Samantha Prout's Past Insider Trading?

Samantha Prout's largest purchase order was 5,931 units , worth over $85.38K on November 6, 2020. Samantha Prout's largest sale order was 5,931 units , worth over $118.62K on November 6, 2020. In total, Samantha Prout has made about 14 transactions over 2 years of their time at Amicus Therapeutics, Inc. Samantha Prout usually trades in January and March, with the busiest year in 2020. The most recent transaction was a sale order of 4,925 units , worth over $59.17K on September 8, 2021.

Samantha Prout

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Samantha Prout's' Mailing Address?

  • Mailing address is C/o Amicus Therapeutics, Inc. 1 Cedar Brook Drive Cranbury NJ 08512 NJ

Amicus Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Other Earnings Plans or Compensations
Change in Pension Value
Other Compensation
Total
John F. Crowley 2020 $719,514 $514,800 $5,479,971 $2,492,491 $1,282,843 $825,505 $11,315,124
John F. Crowley 2019 $656,770 $476,815 $5,327,948 $2,334,850 $234,775 $821,505 $9,852,663
John F. Crowley 2018 $637,640 $445,710 $3,861,699 $1,654,347 - $820,567 $7,419,963
Daphne Quimi 2020 $45 $228,712 $1,534,382 $697,894 - $34,639 $2,947,
Daphne Quimi 2019 $400,000 $212,960 $1,311,492 $538,808 - $17,487 $2,480,747
Daphne Quimi 2018 - - - - - - -
Bradley L. Campbell 2020 $515, $368,872 $2,557,304 $1,163,159 - $33,694 $4,
Bradley L. Campbell 2019 $500,877 $378,788 $2,254,114 $987,822 - $19,538 $4,141,139
Bradley L. Campbell 2018 $468,109 $327,209 $1,411,802 $604,817 - $16,710 $2,828,646
Hung Do 2020 $42 $187,908 $1,461,322 $664,660 - $31,248 $2,772,106
Hung Do 2019 $414,625 $200,678 $1,393,462 $574,732 - $22,129 $2,605,626
Hung Do 2018 - - - - - - -
Ellen S. Rosenberg 2020 $452, $199,051 $1,461,322 $664,660 $87,751 $20,748 $2,885,820
Ellen S. Rosenberg 2019 $439,213 $233,837 $1,393,462 $610,648 - $13,538 $2,690,698
Ellen S. Rosenberg 2018 $426,420 $208,647 $996,591 $426,933 - $18,270 $2,076,862
Jay Barth 2020 $366,269 - $1,315,184 $598,197 - $641,306 $2,920,956
Jay Barth 2019 $471,621 $228,265 $1,229,522 $538,808 - $15,998 $2,484,214
Jay Barth 2018 $457,885 $192,037 $996,591 $426,933 - $18,790 $2,092,236
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1178879/000114036121014545/nc10021408x1_def14a.htm

What are Amicus Therapeutics, Inc's Past Insider Trades?

Amicus Therapeutics, Inc's most recent insider trade came on December 5, 2022 by John Crowley who sold 11,347 units worth $138.47K . In the last 15 years, insiders at Amicus Therapeutics, Inc have sold an estimated value of $176.16M and bought an estimated value of $192.16M worth of shares. Insider trading is most common in June, with the busiest year in 2008. The most active traders at the company are John Crowley, Executive Chairman,  Bradley Campbell, President & CEO,  and James N Topper, Director .

AMICUS THERAPEUTICS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1